Perry C Siatis sold $5.7M of AbbVie (ABBV)

Executed Feb 28 2025, disclosed Mar 4 2025, 4 days later.

Value, as filed

$5.7M

27,537 sh across 3 lots

Executed

Feb 28 2025

the trade date, as filed

Disclosed

Mar 4 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

PS Perry C Siatis EVP, GC AND SECRETARY profile →

Perry C Siatis (EVP, GC AND SECRETARY) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in AbbVie Inc. (ABBV). The largest single filing was $5.1M of ABBV (22,381 sh × $230.00, as filed), executed Feb 25.

The name

ABBV AbbVie Inc. ABBV · Healthcare · 41 filings in 24 months ticker →

Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Perry C Siatis in ABBV

ABBVSALE AbbVie Inc. $4.4M
18,668 sh across 3 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ABBVSALE AbbVie Inc. $5.1M
22,381 sh × $230.00
Exec Feb 25
Filed Feb 27 · 5:30 PM ET ABBVSALE AbbVie Inc. $1.1M
5,778 sh across 2 lots
Exec Feb 20 2025
Filed Feb 24 2025 · 5:30 PM ET